PL2091920T3 - Podstawione pirazole, kompozycje je zawierające, sposób wytwarzania i zastosowanie - Google Patents
Podstawione pirazole, kompozycje je zawierające, sposób wytwarzania i zastosowanieInfo
- Publication number
- PL2091920T3 PL2091920T3 PL07870263T PL07870263T PL2091920T3 PL 2091920 T3 PL2091920 T3 PL 2091920T3 PL 07870263 T PL07870263 T PL 07870263T PL 07870263 T PL07870263 T PL 07870263T PL 2091920 T3 PL2091920 T3 PL 2091920T3
- Authority
- PL
- Poland
- Prior art keywords
- production
- compositions containing
- substituted pyrazoles
- pyrazoles
- substituted
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C273/00—Preparation of urea or its derivatives, i.e. compounds containing any of the groups, the nitrogen atoms not being part of nitro or nitroso groups
- C07C273/18—Preparation of urea or its derivatives, i.e. compounds containing any of the groups, the nitrogen atoms not being part of nitro or nitroso groups of substituted ureas
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/415—1,2-Diazoles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D231/00—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
- C07D231/02—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
- C07D231/10—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
- C07D231/14—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D231/38—Nitrogen atoms
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
FR0609812A FR2908409B1 (fr) | 2006-11-10 | 2006-11-10 | Pyrazoles substituees,compositions les contenant,procede de fabrication et utilisation |
EP07870263.6A EP2091920B1 (fr) | 2006-11-10 | 2007-11-09 | Pyrazoles substituees, compositions les contenant, procede de fabrication et utilisation |
PCT/FR2007/001851 WO2008065282A2 (fr) | 2006-11-10 | 2007-11-09 | Pyrazoles substituees, compositions les contenant, procede de fabrication et utilisation |
Publications (1)
Publication Number | Publication Date |
---|---|
PL2091920T3 true PL2091920T3 (pl) | 2015-04-30 |
Family
ID=38169388
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PL07870263T PL2091920T3 (pl) | 2006-11-10 | 2007-11-09 | Podstawione pirazole, kompozycje je zawierające, sposób wytwarzania i zastosowanie |
Country Status (40)
Country | Link |
---|---|
US (3) | US7989439B2 (pl) |
EP (1) | EP2091920B1 (pl) |
JP (1) | JP5538893B2 (pl) |
KR (1) | KR20090083456A (pl) |
CN (1) | CN101553473B (pl) |
AR (1) | AR063638A1 (pl) |
AU (1) | AU2007327423B2 (pl) |
BR (1) | BRPI0718999A2 (pl) |
CA (1) | CA2667846A1 (pl) |
CL (1) | CL2007003251A1 (pl) |
CO (1) | CO6190516A2 (pl) |
CR (1) | CR10749A (pl) |
CY (1) | CY1116000T1 (pl) |
DK (1) | DK2091920T3 (pl) |
DO (1) | DOP2009000088A (pl) |
EA (1) | EA019454B1 (pl) |
EC (1) | ECSP099312A (pl) |
ES (1) | ES2528385T3 (pl) |
FR (1) | FR2908409B1 (pl) |
HK (1) | HK1137988A1 (pl) |
HN (1) | HN2009000856A (pl) |
HR (1) | HRP20150070T1 (pl) |
IL (1) | IL198328A0 (pl) |
MA (1) | MA30972B1 (pl) |
MX (1) | MX2009004983A (pl) |
MY (1) | MY147502A (pl) |
NI (1) | NI200900078A (pl) |
NO (1) | NO20091990L (pl) |
NZ (1) | NZ576709A (pl) |
PE (2) | PE20121152A1 (pl) |
PL (1) | PL2091920T3 (pl) |
PT (1) | PT2091920E (pl) |
SI (1) | SI2091920T1 (pl) |
SV (1) | SV2009003253A (pl) |
TN (1) | TN2009000155A1 (pl) |
TW (1) | TW200829556A (pl) |
UA (1) | UA97965C2 (pl) |
UY (1) | UY30707A1 (pl) |
WO (1) | WO2008065282A2 (pl) |
ZA (1) | ZA200903560B (pl) |
Families Citing this family (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US7858323B2 (en) * | 2004-06-09 | 2010-12-28 | The Regents Of The University Of Michigan | Phage microarray profiling of the humoral response to disease |
FR2947546B1 (fr) * | 2009-07-03 | 2011-07-01 | Sanofi Aventis | Derives de pyrazoles, leur preparation et leur application en therapeutique |
UY33200A (es) * | 2010-01-26 | 2011-08-31 | Sanofi Aventis | Derivados de ácido 3-heteroaroilamino-propiónico sustituidos con oxígeno y su uso como productos farmacéuticos |
TWI523844B (zh) | 2011-01-26 | 2016-03-01 | 賽諾菲公司 | 經胺基取代之3-雜芳醯基胺基-丙酸衍生物及其作為藥物之用途 |
CN102432639B (zh) * | 2011-09-30 | 2013-11-06 | 山东大学 | 1-(2-羟基-3-(苯氨基)丙基)-3-二茂铁基-1h-吡唑-5-甲酸乙酯化合物及其应用 |
EA201500393A1 (ru) | 2012-11-02 | 2016-05-31 | Пфайзер Инк. | Ингибиторы тирозинкиназы брутона |
BR112017016817A2 (pt) * | 2015-03-25 | 2018-04-03 | Novartis Ag | derivados heterocíclicos formilados como inibidores de fgfr4 |
CN107619388A (zh) * | 2016-07-13 | 2018-01-23 | 南京天印健华医药科技有限公司 | 作为fgfr抑制剂的杂环化合物 |
CN107840842A (zh) | 2016-09-19 | 2018-03-27 | 北京天诚医药科技有限公司 | 炔代杂环化合物、其制备方法及其在医药学上的应用 |
Family Cites Families (12)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6878714B2 (en) * | 2001-01-12 | 2005-04-12 | Amgen Inc. | Substituted alkylamine derivatives and methods of use |
WO2002088090A2 (en) * | 2001-04-27 | 2002-11-07 | Vertex Pharmaceuticals Incorporated | Pyrazole derived kinase inhibitors |
CA2522079A1 (en) * | 2003-04-16 | 2004-11-04 | Astrazeneca Ab | Quinazoline derivatives for treatment of cancer |
US20040220186A1 (en) * | 2003-04-30 | 2004-11-04 | Pfizer Inc. | PDE9 inhibitors for treating type 2 diabetes,metabolic syndrome, and cardiovascular disease |
KR101204247B1 (ko) * | 2003-07-22 | 2012-11-22 | 아스텍스 테라퓨틱스 리미티드 | 3,4-이치환된 1h-피라졸 화합물 및 그의 시클린 의존성키나제 (cdk) 및 글리코겐 합성효소 키나제-3(gsk-3) 조정제로서 용도 |
WO2006003440A1 (en) * | 2004-07-05 | 2006-01-12 | Astex Therapeutics Limited | 3,4-disubstituted pyrazoles as cyclin dependent kinases (cdk) or aurora kinase or glycogen synthase 3 (gsk-3) inhibitors |
US20080261952A1 (en) * | 2004-08-16 | 2008-10-23 | Jason Bloxham | Aryl Urea Derivatives for Treating Obesity |
US20100160324A1 (en) * | 2004-12-30 | 2010-06-24 | Astex Therapeutics Limited | Pyrazole derivatives as that modulate the activity of cdk, gsk and aurora kinases |
JP2008528469A (ja) * | 2005-01-21 | 2008-07-31 | アステックス・セラピューティクス・リミテッド | ピラゾールキナーゼ阻害剤およびさらなる抗癌剤の組合せ剤 |
AR052559A1 (es) * | 2005-01-21 | 2007-03-21 | Astex Therapeutics Ltd | Derivados de pirazol para inhibir cdk's y gsk's |
EP1683796A1 (en) * | 2005-01-24 | 2006-07-26 | Schering Aktiengesellschaft | Pyrazolopyridines, their preparation and their medical use |
FR2947546B1 (fr) * | 2009-07-03 | 2011-07-01 | Sanofi Aventis | Derives de pyrazoles, leur preparation et leur application en therapeutique |
-
2006
- 2006-11-10 FR FR0609812A patent/FR2908409B1/fr not_active Expired - Fee Related
-
2007
- 2007-11-08 TW TW096142249A patent/TW200829556A/zh unknown
- 2007-11-09 PL PL07870263T patent/PL2091920T3/pl unknown
- 2007-11-09 NZ NZ576709A patent/NZ576709A/en not_active IP Right Cessation
- 2007-11-09 EA EA200970472A patent/EA019454B1/ru not_active IP Right Cessation
- 2007-11-09 BR BRPI0718999-0A2A patent/BRPI0718999A2/pt not_active IP Right Cessation
- 2007-11-09 AU AU2007327423A patent/AU2007327423B2/en not_active Ceased
- 2007-11-09 PE PE2012000296A patent/PE20121152A1/es not_active Application Discontinuation
- 2007-11-09 CA CA002667846A patent/CA2667846A1/fr not_active Abandoned
- 2007-11-09 DK DK07870263.6T patent/DK2091920T3/en active
- 2007-11-09 KR KR1020097011936A patent/KR20090083456A/ko active IP Right Grant
- 2007-11-09 WO PCT/FR2007/001851 patent/WO2008065282A2/fr active Application Filing
- 2007-11-09 ES ES07870263.6T patent/ES2528385T3/es active Active
- 2007-11-09 CN CN200780045533XA patent/CN101553473B/zh not_active Expired - Fee Related
- 2007-11-09 EP EP07870263.6A patent/EP2091920B1/fr active Active
- 2007-11-09 AR ARP070105002A patent/AR063638A1/es not_active Application Discontinuation
- 2007-11-09 CL CL2007003251A patent/CL2007003251A1/es unknown
- 2007-11-09 ZA ZA200903560A patent/ZA200903560B/xx unknown
- 2007-11-09 MY MYPI20091827A patent/MY147502A/en unknown
- 2007-11-09 UY UY30707A patent/UY30707A1/es not_active Application Discontinuation
- 2007-11-09 MX MX2009004983A patent/MX2009004983A/es active IP Right Grant
- 2007-11-09 PT PT78702636T patent/PT2091920E/pt unknown
- 2007-11-09 PE PE2007001548A patent/PE20081162A1/es not_active Application Discontinuation
- 2007-11-09 JP JP2009535773A patent/JP5538893B2/ja not_active Expired - Fee Related
- 2007-11-09 SI SI200731592T patent/SI2091920T1/sl unknown
- 2007-11-09 UA UAA200905930A patent/UA97965C2/ru unknown
-
2009
- 2009-04-23 DO DO2009000088A patent/DOP2009000088A/es unknown
- 2009-04-23 IL IL198328A patent/IL198328A0/en unknown
- 2009-04-24 TN TNP2009000155A patent/TN2009000155A1/fr unknown
- 2009-04-24 CR CR10749A patent/CR10749A/es unknown
- 2009-05-05 EC EC2009009312A patent/ECSP099312A/es unknown
- 2009-05-06 NI NI200900078A patent/NI200900078A/es unknown
- 2009-05-07 SV SV2009003253A patent/SV2009003253A/es unknown
- 2009-05-07 CO CO09046036A patent/CO6190516A2/es active IP Right Grant
- 2009-05-08 HN HN2009000856A patent/HN2009000856A/es unknown
- 2009-05-08 US US12/437,618 patent/US7989439B2/en not_active Expired - Fee Related
- 2009-05-22 NO NO20091990A patent/NO20091990L/no not_active Application Discontinuation
- 2009-06-05 MA MA31959A patent/MA30972B1/fr unknown
-
2010
- 2010-03-26 HK HK10103174.0A patent/HK1137988A1/xx not_active IP Right Cessation
-
2011
- 2011-06-09 US US13/156,915 patent/US8410286B2/en not_active Expired - Fee Related
- 2011-06-09 US US13/156,947 patent/US8420824B2/en not_active Expired - Fee Related
-
2015
- 2015-01-20 HR HRP20150070TT patent/HRP20150070T1/hr unknown
- 2015-01-22 CY CY20151100068T patent/CY1116000T1/el unknown
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
HRP20190408T1 (hr) | Ariloazol-2-il-cijanoetilamino-spojevi, postupak njihove proizvodnje i postupak njihove uporabe | |
HRP20150070T1 (hr) | Supstituirani pirazoli, pripravci koji ih sadrže, postupak njihovog dobivanja i upotreba | |
ZA200810673B (en) | 1-aryl-5-alkyl pyrazole derivative compounds, processes of making and methods of using thereof | |
ZA200901634B (en) | Substituted Amides, method of making, and method of use thereof | |
ZA200901633B (en) | Certain substituted amides, method of making, and method of use thereof | |
IL190477A0 (en) | Pyrazole derivatives, compositions containing such compounds and methods of use | |
IL197528A0 (en) | Synthesis, methods of using, and compositions of cycloalkylmethylamines | |
PL1816116T6 (pl) | Kompozycje chemiczne i sposoby ich wytwarzania | |
EP2340297A4 (en) | COMPOSITION, ITS MANUFACTURING METHOD AND USE | |
ZA200806434B (en) | Calcium-enrichment compositions and methods for production thereof |